Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy

Abstract

Background and study aims Unsedated transnasal endoscopy (uTNE) has become accepted as a safe and tolerable method for upper gastrointestinal tact examinations. Epistaxis is 1 of the major complications of TNE, though its risk factors have not been elucidated. Generally, patients administered an anticoagulant or antiplatelet drug are considered to have an increased risk of epistaxis during TNE. Here, we investigated risk factors of epistaxis in patients undergoing uTNE, with focus on those who received antithrombotic agents.

Patients and methods We enrolled 6860 patients (average age 55.6 ± 12.97 years; 3405 males, 3455 females) who underwent uTNE and received the same preparations for the procedure. Epistaxis was evaluated using endoscopic images obtained while withdrawing the scope through the nostril. We also noted current use of medications including anticoagulant or antiplatelet agents prior to the endoscopic examination.

Results Epistaxis occurred in 3.6 % of the enrolled patients (245/6860), and that rate was significantly higher in younger patients (average age 49.31 ± 11.8 years for epistaxis group vs. 55.83 ± 13.0 years for no epistaxis group, P < 0.01) as well as females (4.78 % vs. 2.35 %, P < 0.01). The odds ratio for occurrence of epistaxis was 2.31 (95 %CI: 1.746 – 3.167) in the younger patients and 2.02 (95 % CI: 1.542 – 2.659) in females. In contrast, there was no significant difference for rate of epistaxis between patients with and without treatment with an antithrombotic agent (3.0 % vs. 3.6 %).

Conclusions The rate of epistaxis was higher in younger and female patients. Importantly, that rate was not significantly increased in patients who were administered an antithrombotic agent.

• References

• 1 Yagi J, Adachi K, Arima N. et al. A prospective randomized comparative study on the safety and tolerability of transnasal duodenoscopy. Endoscopy 2005; 37: 1226-1231
• 2 Yuki M, Amano Y, Komazawa Y. et al. Unsedated transnasal small-caliber esophagogastroduodenoscopy in elderly and bedridden patients. World J Gastroenterol 2009; 15: 5586-5591
• 3 Tatsumi Y, Harada A, Matsumoto T. et al. Current status and evaluation of transnasal esophagogastroduodenoscopy. Digestive Endosc 2009; 21: 141-146
• 4 Waring JP, Baron TH, Hirota WK. et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 2003; 58: 317-322
• 5 Trevisani L, Sartori S, Gaudenzi P. et al. Upper gastrointestinal endoscopy: are preparatory interventions or conscious sedation effective? A randomized trial. World J Gastroenterol 2004; 10: 3313-3317
• 6 Shariff MK, Bird-Lieberman EL, O'Donovan M. et al. Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Gastrointest Endosc 2012; 75: 954-61
• 7 Huang YC, Lee YC, Tseng PH. et al. Regular screening of esophageal cancer for 248 newly diagnosed hypopharyngeal squamous cell carcinoma by unsedated transnasal esophagogastroduodenoscopy. Oral Oncol 2016; 55: 55-60
• 8 Choe WH, Kim JH, Ko SY. et al. Comparison of transnasal small-caliber vs. peroral conventional esophagogastroduodenoscopy for evaluating varices in unsedated cirrhotic patients. Endoscopy 2011; 43: 649-656
• 9 Ai ZL, Lan CH, Fan LL. et al. Unsedated transnasal upper gastrointestinal endoscopy has favorable diagnostic effectiveness, cardiopulmonary safety, and patient satisfaction compared with conventional or sedated endoscopy. Surg Endosc 2012; 26: 3565-3572
• 10 Kadayifci A, Atar M, Parlar S. et al. Transnasal endoscopy is preferred by transoral endoscopy experienced patients. J Gastrointestin Liver Dis 2014; 23: 27-31
• 11 Maffei M, Dumonceau JM. Transnasal esogastroduodenoscopy (EGD): comparison with conventional EGD and new applications. Swiss Med Wkly 2008; 138: 658-664
• 12 Cho S, Arya N, Swan K. et al. Unsedated transnasal endoscopy: a Canadian experience in daily practice. Can J Gastroenterol 2008; 22: 243-246
• 13 Stroppa I, Grasso E, Paoluzi OA. et al. Unsedated transnasal versus transoral sedated upper gastrointestinal endoscopy: a one-series prospective study on safety and patient acceptability. Dig Liver Dis 2008; 40: 767-775
• 14 Lee SY, Kawai T. Transnasal route: new approach to endoscopy. Gut Liver 2008; 2: 155-165
• 15 Watanabe H, Watanabe N, Ogura R. et al. A randomized prospective trial comparing unsedated endoscopy via transnasal and transoral routes using 5.5-mm video endoscopy. Dig Dis Sci 2009; 54: 2155-2160
• 16 Trevisani L, Cifalà V, Sartori S. et al. Unsedated ultrathin upper endoscopy is better than conventional endoscopy in routine outpatient gastroenterology practice: a randomized trial. World J Gastroenterol 2007; 13: 906-911
• 17 Maffei M, Dumonceau JM. Transnasal esophagogastroduodenoscopy (EGD): comparison with conventional EGD and new applications. Swiss Med Wkly 2008; 138: 658-664
• 18 Mori A. Reporting the how, where, and grading of nasomucosal injury after transnasal endoscopy (Letter reply to Hu). Endoscopy 2010; 42: 689
• 19 Acosta RD, Abraham NS, Chandrasekhara V. et al. The management of antithrombotic agents for patients undergoing gastrointestinal endoscopy. Gastrointest Endosc 2016; 83: 3-16
• 20 Veitch AM, Vanbiervliet G, Gershlick AH. et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut 2016; 65: 374-389
• 21 Lip GY, Nieuwlaat R, Pisters R. et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272
• 22 Ono S, Fujishiro M, Kodashima S. et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J Gastroenterol 2012; 47: 770-774
• 23 Whitson MJ, Dikman AE, von Althann C. et al. Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel: a prospective, randomized study involving 630 biopsies. J Clin Gastroenterol 2011; 45: 228-233
• 24 Ono S, Niimi K, Fujishiro M. et al. Evaluation of preferable insertion routes for esophagogastroduodenoscopy using ultrathin endoscopes. World J Gastroenterol 2014; 20: 5045-5050
• 25 Ono S, Niimi K, Fujishiro M. et al. Ultrathin endoscope flexibility can predict discomfort associated with unsedated transnasal esophagogastroduodenoscopy. World J Gastrointest Endosc 2013; 5: 346-351
• 26 Preiss C, Charton JP, Schumacher B. et al. A randomized trial of unsedated transnasal small-caliber esophagogastroduodenoscopy (EGD) versus peroral small-caliber EGD versus conventional EGD. Endoscopy 2003; 35: 641-646
• 27 Cheung J, Bailey R, Veldhuyzen van Zanten S. et al. Early experience with unsedated ultrathin 4.9 mm transnasal gastroscopy: a pilot study. Can J Gastroenterol 2008; 22: 917-922
• 28 Murata A, Akahoshi K, Sumida Y. et al. Prospective randomized trial of transnasal versus peroral endoscopy using an ultrathin videoendoscope in unsedated patients. J Gastroenterol Hepatol 2007; 22: 482-485
• 29 Hu CT. Anterior meatuscopy is more reliable than a sniff test for predicting nasal patency before transnasal endoscopy. Endosc Int Open 2015; 3: E538-E546